Variables |  | Groups (mean ± SD) | F value | P value | |
---|---|---|---|---|---|
Galvanic group | Control group | ||||
Canal weakness | Pre-treatment | 57.75 ± 20.21 | 58.64 ± 23.13 | 0.016 | 0.901 (NS) |
Post-treatment | 22.30 ± 22.42 | 45.00 ± 23.61 | 8.972 | 0.005 (S) | |
Mean difference | 35.45 | 13.64 | Â | Â | |
Improvement % | 61.39% | 23.26% | Â | Â | |
F value | 27.578 | 2.897 | Â | Â | |
P value | 0.0001 (S) | 0.098 (NS) | Â | Â | |
Total equilibrium composite | Pre-treatment | 39.60 ± 11.16 | 45.71 ± 12.99 | 2.365 | 0.133 (NS) |
Post-treatment | 66.95 ± 16.69 | 49.12 ± 13.98 | 12.145 | 0.001 (S) | |
Mean difference | 27.35 | 3.41 | Â | Â | |
Improvement % | 69.07% | 7.46% | Â | Â | |
F value | 37.109 | 0.543 | Â | Â | |
P value | 0.0001 (S) | 0.467 (NS) | Â | Â | |
Somatosensory score | Pre-treatment | 90.35 ± 8.57 | 91.76 ± 9.35 | 0.230 | 0.634 (NS) |
Post-treatment | 95.65 ± 5.30 | 94.29 ± 7.48 | 0.413 | 0.524 (NS) | |
Mean difference | 5.30 | 2.53 | Â | Â | |
Improvement % | 5.87% | 2.76% | Â | Â | |
F value | 5.528 | 0.758 | Â | Â | |
P value | 0.024 (S) | 0.390 (NS) | Â | Â | |
Visual score | Pre-treatment | 39.76 ± 7.08 | 41.77 ± 26.29 | 0.108 | 0.744 (NS) |
Post-treatment | 55.75 ± 21.20 | 41.94 ± 27.53 | 2.966 | 0.094 (NS) | |
Mean difference | 15.99 | 0.17 | Â | Â | |
Improvement % | 40.22% | 0.41% | Â | Â | |
F value | 10.227 | 0.000 | Â | Â | |
P value | 0.003 (S) | 0.985 (NS) | Â | Â | |
Vestibular score | Pre-treatment | 25.72 ± 19.78 | 19.47 ± 19.48 | 0.929 | 0.342 (NS) |
Post-treatment | 45.75 ± 25.46 | 21.76 ± 21.56 | 9.364 | 0.004 (S) | |
Mean difference | 20.03 | 2.29 | Â | Â | |
Improvement % | 77.88% | 11.76% | Â | Â | |
F value | 7.722 | 0.106 | Â | Â | |
P value | 0.008 (S) | 0.747 (NS) | Â | Â | |
Preference score | Pre-treatment | 76.60 ± 8.25 | 82.72 ± 9.02 | 3.207 | 0.082 (NS) |
Post-treatment | 90.55 ± 8.56 | 94.56 ± 7.96 | 1.664 | 0.205 (NS) | |
Mean difference | 13.95 | 11.84 | Â | Â | |
Improvement % | 18.21% | 14.31% | Â | Â | |
F value | 27.513 | 9.131 | Â | Â | |
P value | 0.0001 (S) | 0.005 (S) | Â | Â | |
VADL score | Pre-treatment | 101.75 ± 29.42 | 94.59 ± 45.74 | 0.330 | 0.569 (NS) |
Post-treatment | 62.20 ± 21.99 | 67.18 ± 37.08 | 0.255 | 0.616 (NS) | |
Mean difference | 39.55 | 27.41 | Â | Â | |
Improvement % | 38.87% | 28.98% | Â | Â | |
F value | 23.182 | 6.684 | Â | Â | |
P value | 0.0001 (S) | 0.024 (S) | Â | Â |